Varewijck, A J <br/><br/>
Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly.  [electronic resource] 

 -  Diabetologia  Apr 2012 
 - 1186-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-011-2435-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Glargine<br/>Insulin, Isophane--therapeutic use<br/>Insulin, Long-Acting--therapeutic use<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged